823735429 · AZ ↑ parent cluster ·
research card →

Shay Emma Hammer Research Foundtion

AZ · EIN 823735429 · $223K rev · research · shaysgift.org
profile

The Shay Emma Hammer Research Foundation (SEHRF) funds and conducts translational research to understand the causes of epilepsy, particularly SCN8A-related disorders, and to identify new therapies. The organization focuses on genetic, molecular, and cellular studies, including the use of animal models and human cell lines, to bridge laboratory discoveries with clinical practice. Their work aims to improve treatment and find a cure for childhood epilepsy and other neurological disorders.

activities · 5

what they do

advocacy · 1
research · 3
  • Collaborating with the University of Arizona Hammer Lab Pediatric Neurological Autoimmune Disorder Research and Treatment
    The organization collaborates with the University of Arizona Hammer Lab to support children with SCN8A-related disorders, expand understanding of the global SCN8A community, and conduct extensive research to find cures for SCN8A, other forms of epilepsy, and childhood disorders.
  • The organization funds innovative research to advance therapies and develop new treatments for epilepsy and other childhood brain disorders, with a specific focus on SCN8A-related disorders, aiming to improve current therapies and reduce side effects.
  • The organization sponsors the SCN8A Registry, a scientific data collection platform that gathers patient-reported information to advance the understanding of SCN8A-related epilepsy, generate crucial data, and identify disease features for drug development.
capacity building · 1
strategies · 3

how they think

Theories of action extracted from this org's own source material. Click any to see the full field of orgs running the same approach.

named programs · 5

what they call their work

Animal Models
Research utilizing animal models, particularly mouse strains with genetic mutations known to cause seizures in humans (e.g., SCN8A gene mutations), to understand epileptogenesis and identify potential therapeutic agents.
Functional Studies
Research focused on uncovering the effects of changes in molecules, ion channels, and brain cells in epilepsy and brain disorders, including the study of ion channel mutations and their impact on neuronal activity.
Integrative Treatment Research
Supporting scientific research into both conventional and alternative therapies for epilepsy, including natural products, nutraceuticals, and approaches like the ketogenic diet, to find new and effective treatments.
Neuronal Cell Lines (iPSC)
Research using induced pluripotent stem cells (iPSCs) derived from patients to create human models of epilepsy in the laboratory, allowing for the study of disease mechanisms in the context of a person's unique genetic makeup and for testing drug effects on human brain cells.
Omics
Research employing next-generation laboratory tools to study DNA, RNA, and protein data from cells to understand the molecular makeup and cellular pathways underlying childhood epilepsy and brain disorders, aiming to identify abnormal processes and new biomarkers.
relationships · 12

who they work with

  • Arizona Public Media Partner — Produced a video about Shay's story.
  • BIO5 Institute Partner — Listed as a contact location for the organization.
  • Joseph Watkins Partner — Primary collaborator with the Hammer Lab, professor in the Department of Mathematics and Director of the Data Sciences Academy.
  • Octavia Digital Media Partner — Designed the organization's website.
  • SCN8A International Patient Registry Partner — Joshua Hack applies machine learning techniques to this registry.
  • SCN8A.net Partner — Hosts the SCN8A Registry sponsored by SEHRF for data collection and research on SCN8A-related epilepsy.
  • University of Arizona Partner — Dr. Hammer was the Director of the University of Arizona's Genetics Core and received approval from the University to conduct research.
  • University of Arizona Partner — Listed as a contact location for the organization.
  • University of Arizona Partner — Michael Hammer's research began here in 1991; several lab members are current or past students/graduates.
  • University of Arizona Hammer Lab Partner — Collaborates with SEHRF on research and registry efforts for SCN8A-related disorders.
  • University of Arizona, R. Ken Coit College of Pharmacy Partner — Taylor Lynn Camacho is an undergraduate student majoring in Pharmaceutical Sciences.
  • University of California- Los Angeles Partner — Joshua Hack will pursue a Ph.D. in Genetics and Genomics there starting in Fall 2024.